N-acetyltransferase 10 mediates cognitive dysfunction through the acetylation of GABA B R1 mRNA in sepsis-associated encephalopathy.
Shenjia GaoRuling ShenJie LiYi JiangHao SunXinyi WuXiya LiChanghong MiaoMiao HeJun WangWan-Kun ChenPublished in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Sepsis-associated encephalopathy (SAE) is a critical neurological complication of sepsis and represents a crucial factor contributing to high mortality and adverse prognosis in septic patients. This study explored the contribution of NAT10-mediated messenger RNA (mRNA) acetylation in cognitive dysfunction associated with SAE, utilizing a cecal ligation and puncture (CLP)-induced SAE mouse model. Our findings demonstrate that CLP significantly upregulates NAT10 expression and mRNA acetylation in the excitatory neurons of the hippocampal dentate gyrus (DG). Notably, neuronal-specific Nat10 knockdown improved cognitive function in septic mice, highlighting its critical role in SAE. Proteomic analysis, RNA immunoprecipitation, and real-time qPCR identified GABA B R1 as a key downstream target of NAT10. Nat10 deletion reduced GABA B R1 expression, and subsequently weakened inhibitory postsynaptic currents in hippocampal DG neurons. Further analysis revealed that microglia activation and the release of inflammatory mediators lead to the increased NAT10 expression in neurons. Microglia depletion with PLX3397 effectively reduced NAT10 and GABA B R1 expression in neurons, and ameliorated cognitive dysfunction induced by SAE. In summary, our findings revealed that after CLP, NAT10 in hippocampal DG neurons promotes GABA B R1 expression through mRNA acetylation, leading to cognitive dysfunction.
Keyphrases
- poor prognosis
- binding protein
- acute kidney injury
- spinal cord
- mouse model
- long non coding rna
- type diabetes
- end stage renal disease
- cerebral ischemia
- chronic kidney disease
- emergency department
- early onset
- oxidative stress
- single cell
- septic shock
- cardiovascular disease
- newly diagnosed
- blood brain barrier
- drug induced